Clinical Trial Update: Prolonged-Use of Inhaled Gaseous Nitric Oxide (gNO) for Adult With Non-Tuberculous Mycobacteria Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prolonged use of inhaled gaseous nitric oxide for non-tuberculous mycobacterial pneumonia is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-tuberculous Mycobacterial Pneumonia

Snippet

Sponsor: University of British Columbia | Conditions: Non-Tuberculous Mycobacterial Pneumonia | Phase 2 | Status: COMPLETED